IBM's Q1 Beat Sparks Selloff as Investors Weigh AI Threat Against Mainframe Boom
27.04.2026 - 21:01:37 | boerse-global.de
Big Blue delivered a quarter that would make most CEOs envious — and the market punished it anyway. IBM's first-quarter results topped Wall Street forecasts on both revenue and earnings, yet the stock tumbled 8.25 percent in after-hours trading. The selloff has deepened since, leaving shares roughly 21 percent lower year-to-date.
The disconnect stems from a single decision: management refused to lift its full-year guidance. CFO Jim Kavanaugh defended the stance during an earnings call, noting that IBM has never raised its annual forecast in the first quarter. That caution, however, clashed with the strength of the numbers themselves. Revenue hit $15.92 billion, comfortably ahead of analyst estimates, while earnings per share of $1.91 also exceeded expectations.
A Rare Bullish Call Emerges
Against the prevailing gloom, DZ Bank analyst Ingo Wermann upgraded IBM from Hold to Buy with a $295 price target. His argument centers on valuation: IBM trades at a discount to other AI-related names on a forward price-to-earnings basis, even as its software mix expands and margins improve. The stock's low beta of 0.685, he notes, underscores its defensive qualities.
That view is far from unanimous. BMO Capital Markets trimmed its target to $270 while maintaining a neutral rating, and JPMorgan followed suit with the same figure. Morgan Stanley raised its target to $225 — still below the current share price. The broader analyst consensus sits at roughly $302.
Should investors sell immediately? Or is it worth buying IBM?
Mainframes Surge, Red Hat Slows
The quarter's standout performer was the infrastructure segment, which generated $3.33 billion in revenue — well above expectations. Z-mainframe hardware sales jumped 51 percent, a dramatic acceleration that caught many on Wall Street off guard.
Yet the software picture is more nuanced. Revenue from that division rose 11 percent to $7.1 billion, but Red Hat, IBM's crown-jewel growth engine, is losing momentum. Kavanaugh attributed the deceleration to lingering effects of the US government shutdown in late 2025 and persistent hardware supply-chain disruptions.
The consulting business, long used as a client-retention tool, faces a more existential challenge. AI is starting to cannibalize the very services IBM has relied on for decades. In February, the stock lost 13 percent in a single session after Anthropic claimed its AI could help modernize COBOL code — the lifeblood of IBM's mainframe ecosystem. The shares have never fully recovered from that blow.
AI Adoption Creates a Paradox
Watsonx, IBM's AI platform, has been adopted by 95 percent of Fortune 500 companies — a statistic that suggests deep market penetration. But the same technology that drives efficiency in client operations also threatens IBM's traditional consulting revenue streams. The market is struggling to decide whether the company is an AI winner or an AI loser, and that ambiguity is fueling volatility.
The company's internal transformation program, meanwhile, is delivering tangible cost savings. By deploying AI and data automation at scale, IBM has generated billions in efficiencies since 2023, pushing its adjusted EBITDA margin up 170 basis points.
Confluent Deal Strains the Balance Sheet
IBM closed its $11.6 billion acquisition of Confluent during the quarter, creating $7.2 billion in goodwill. Total debt has climbed $5.1 billion since the start of the year to $66.4 billion, while long-term borrowings stand at $57.7 billion.
Operating cash flow improved to $5.2 billion, and the remaining performance obligations total roughly $69 billion — about 69 percent of which is expected to convert to revenue within the next two years. That backlog provides visibility, but only if integration proceeds smoothly.
IBM at a turning point? This analysis reveals what investors need to know now.
Dividend Streak Continues
Shareholders received some consolation. IBM raised its quarterly dividend to $1.69 per share, payable June 10, marking the 31st consecutive year of increases. The company has paid uninterrupted quarterly dividends since 1916, and the latest payout totaled $1.6 billion in the first quarter alone.
What Comes Next
For the full year 2026, management continues to target currency-adjusted revenue growth above 5 percent, with free cash flow expected to rise by roughly $1 billion. The stock currently trades near $195, about 28 percent below its 52-week high.
The next major catalyst arrives July 22, when IBM reports second-quarter results. By then, investors will have a clearer picture of whether the mainframe momentum can persist and whether Confluent is beginning to deliver on its integration promise. Until that data point arrives, the stock appears destined to remain caught between record operational performance and persistent strategic uncertainty.
Ad
IBM Stock: New Analysis - 27 April
Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
So schätzen die Börsenprofis IBMs Aktien ein!
Für. Immer. Kostenlos.
